Stock Price
9.38
Daily Change
-0.02 -0.21%
Monthly
0.64%
Yearly
37.54%
Q1 Forecast
9.00

Grifols reported EUR333.1M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Alaunos Therapeutics USD 585K 260K Sep/2025
aTyr Pharma USD 4.8M 130K Sep/2025
GlaxoSmithKline GBP 2.16B 19M Sep/2025
Grifols EUR 333.1M 157M Sep/2025